vs
ICU MEDICAL INC（ICUI）与Ryman Hospitality Properties, Inc.（RHP）财务数据对比。点击上方公司名可切换其他公司
Ryman Hospitality Properties, Inc.的季度营收约是ICU MEDICAL INC的1.4倍（$737.8M vs $540.7M），Ryman Hospitality Properties, Inc.净利率更高（10.1% vs -2.9%，领先13.0%），Ryman Hospitality Properties, Inc.同比增速更快（13.9% vs -14.1%），Ryman Hospitality Properties, Inc.自由现金流更多（$58.5M vs $36.0M），过去两年Ryman Hospitality Properties, Inc.的营收复合增速更高（18.2% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
ICUI vs RHP — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $737.8M |
| 净利润 | $-15.7M | $74.5M |
| 毛利率 | 37.5% | 41.4% |
| 营业利润率 | 1.0% | 19.4% |
| 净利率 | -2.9% | 10.1% |
| 营收同比 | -14.1% | 13.9% |
| 净利润同比 | 34.0% | 3.0% |
| 每股收益（稀释后） | $-0.63 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $737.8M | ||
| Q3 25 | $537.0M | $592.5M | ||
| Q2 25 | $548.9M | $659.5M | ||
| Q1 25 | $604.7M | $587.3M | ||
| Q4 24 | $629.8M | $647.6M | ||
| Q3 24 | $589.1M | $550.0M | ||
| Q2 24 | $596.5M | $613.3M | ||
| Q1 24 | $566.7M | $528.3M |
| Q4 25 | $-15.7M | $74.5M | ||
| Q3 25 | $-3.4M | $34.9M | ||
| Q2 25 | $35.3M | $71.8M | ||
| Q1 25 | $-15.5M | $63.0M | ||
| Q4 24 | $-23.8M | $72.3M | ||
| Q3 24 | $-33.0M | $59.0M | ||
| Q2 24 | $-21.4M | $100.8M | ||
| Q1 24 | $-39.5M | $42.8M |
| Q4 25 | 37.5% | 41.4% | ||
| Q3 25 | 37.4% | 40.9% | ||
| Q2 25 | 37.9% | 49.7% | ||
| Q1 25 | 34.7% | 44.4% | ||
| Q4 24 | 36.1% | 40.4% | ||
| Q3 24 | 34.8% | 43.1% | ||
| Q2 24 | 34.8% | 48.4% | ||
| Q1 24 | 32.7% | 41.5% |
| Q4 25 | 1.0% | 19.4% | ||
| Q3 25 | 2.6% | 15.0% | ||
| Q2 25 | 1.9% | 21.1% | ||
| Q1 25 | 2.1% | 19.8% | ||
| Q4 24 | 6.0% | 18.6% | ||
| Q3 24 | 1.4% | 19.3% | ||
| Q2 24 | 1.3% | 27.4% | ||
| Q1 24 | -1.9% | 18.2% |
| Q4 25 | -2.9% | 10.1% | ||
| Q3 25 | -0.6% | 5.9% | ||
| Q2 25 | 6.4% | 10.9% | ||
| Q1 25 | -2.6% | 10.7% | ||
| Q4 24 | -3.8% | 11.2% | ||
| Q3 24 | -5.6% | 10.7% | ||
| Q2 24 | -3.6% | 16.4% | ||
| Q1 24 | -7.0% | 8.1% |
| Q4 25 | $-0.63 | $1.12 | ||
| Q3 25 | $-0.14 | $0.53 | ||
| Q2 25 | $1.43 | $1.12 | ||
| Q1 25 | $-0.63 | $1.00 | ||
| Q4 24 | $-0.97 | $1.12 | ||
| Q3 24 | $-1.35 | $0.94 | ||
| Q2 24 | $-0.88 | $1.65 | ||
| Q1 24 | $-1.63 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $471.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $750.2M |
| 总资产 | $4.1B | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $471.4M | ||
| Q3 25 | — | $483.3M | ||
| Q2 25 | — | $420.6M | ||
| Q1 25 | — | $413.9M | ||
| Q4 24 | $308.6M | $477.7M | ||
| Q3 24 | $312.5M | $534.9M | ||
| Q2 24 | $302.6M | $498.4M | ||
| Q1 24 | $251.4M | $465.3M |
| Q4 25 | $2.1B | $750.2M | ||
| Q3 25 | $2.1B | $758.5M | ||
| Q2 25 | $2.1B | $800.4M | ||
| Q1 25 | $2.0B | $531.5M | ||
| Q4 24 | $2.0B | $549.0M | ||
| Q3 24 | $2.0B | $551.9M | ||
| Q2 24 | $2.0B | $562.6M | ||
| Q1 24 | $2.1B | $529.9M |
| Q4 25 | $4.1B | $6.2B | ||
| Q3 25 | $4.1B | $6.2B | ||
| Q2 25 | $4.1B | $6.1B | ||
| Q1 25 | $4.2B | $5.2B | ||
| Q4 24 | $4.2B | $5.2B | ||
| Q3 24 | $4.3B | $5.2B | ||
| Q2 24 | $4.3B | $5.1B | ||
| Q1 24 | $4.3B | $5.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $164.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $58.5M |
| 自由现金流率自由现金流/营收 | 6.6% | 7.9% |
| 资本支出强度资本支出/营收 | 4.6% | 14.4% |
| 现金转化率经营现金流/净利润 | — | 2.21× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $232.4M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $164.7M | ||
| Q3 25 | $56.7M | $205.2M | ||
| Q2 25 | $11.2M | $122.5M | ||
| Q1 25 | $51.3M | $98.2M | ||
| Q4 24 | $40.2M | $166.6M | ||
| Q3 24 | $36.1M | $218.1M | ||
| Q2 24 | $82.0M | $184.3M | ||
| Q1 24 | $45.8M | $7.5M |
| Q4 25 | $36.0M | $58.5M | ||
| Q3 25 | $27.6M | $135.4M | ||
| Q2 25 | $-8.5M | $53.0M | ||
| Q1 25 | $36.7M | $-14.5M | ||
| Q4 24 | $16.1M | $76.0M | ||
| Q3 24 | $16.2M | $85.7M | ||
| Q2 24 | $62.5M | $78.8M | ||
| Q1 24 | $29.9M | $-72.0M |
| Q4 25 | 6.6% | 7.9% | ||
| Q3 25 | 5.1% | 22.9% | ||
| Q2 25 | -1.5% | 8.0% | ||
| Q1 25 | 6.1% | -2.5% | ||
| Q4 24 | 2.6% | 11.7% | ||
| Q3 24 | 2.7% | 15.6% | ||
| Q2 24 | 10.5% | 12.9% | ||
| Q1 24 | 5.3% | -13.6% |
| Q4 25 | 4.6% | 14.4% | ||
| Q3 25 | 5.4% | 11.8% | ||
| Q2 25 | 3.6% | 10.5% | ||
| Q1 25 | 2.4% | 19.2% | ||
| Q4 24 | 3.8% | 14.0% | ||
| Q3 24 | 3.4% | 24.1% | ||
| Q2 24 | 3.3% | 17.2% | ||
| Q1 24 | 2.8% | 15.0% |
| Q4 25 | — | 2.21× | ||
| Q3 25 | — | 5.88× | ||
| Q2 25 | 0.32× | 1.71× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 3.70× | ||
| Q2 24 | — | 1.83× | ||
| Q1 24 | — | 0.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |
